Surveyor Capital

Activity from announced rounds

All recorded activity
Rounds participated in
5
Confirmed lead rounds
0
2 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$1.3B
5 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series B2

By primary sector

Biotech5

By country

United States4
Denmark1

Rounds

5 in all activity
Marrow Therapeutics

Marrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.

$120MSeries B
Participant
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed
Kailera Therapeutics

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

$600MSeries B
Participant